SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending due to growing excitement around its potential role in powering AI data centers and a recent partnership, driving speculation and retail investor interest. The community is actively discussing its high valuation relative to its pre-revenue status, debating whether it's a sustainable investment or a speculative bubble. Some traders are noting technical breakouts and potential for further gains, while others remain cautious, citing the risks associated with its long-term commercialization timeline.

AGM Group Holdings, Inc. is a technology company, which engages in the provision of financial solutions. It focuses on the research and development of blockchain-oriented ASIC chip, production of encryption mining machines, and financial technology software services. Its products and services include technology hardware research and development, and assembling and sales of technology hardware. The company was founded by Zhen Tao Jiang and Wen Jie Tang on April 27, 2015 and is headquartered in Hong Kong.

AGM Group Holdings Inc - Ordinary Shares - Class A

AGM Group Holdings is trending due to the completion of a subsidiary sale for $57.45 million, leading to discussions about the company's future strategy and potential for a special dividend. Community members are debating whether the stock is primed for a significant squeeze, while some caution against potential pump-and-dump schemes often associated with Chinese stocks. The stock's low float and high short interest are also contributing to the heightened interest.

Brera Holdings Plc engages in the business of football division progression, global football player transfer service, sponsorship services, football school services, and consulting services on football projects. The company was founded on June 30, 2022 and is headquartered in Dublin, Ireland.

Brera Holdings PLC - Ordinary Shares - Class B

Brera Holdings PLC

BREA is trending due to news of a $300M private investment for a Solana-based digital asset treasury, drawing attention from investors like ARK Invest. Community discussions revolve around potential price targets and the possibility of a short squeeze, with some comparing it to other crypto treasury plays. The stock's low float and news-driven momentum contribute to its volatile price action and heightened interest.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is trending amid optimism surrounding potential interest rate cuts and a possible inclusion in the S&P 500, fueling discussions of a short squeeze. The community is actively debating whether the stock will break through resistance levels and reach new all-time highs, or if profit-taking will lead to a pullback. Bullish sentiment is further supported by analyst upgrades and the anticipation of strong future earnings reports.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending due to a mix of factors, including a recently raised price target and discussion of potential government contracts. Community members are actively debating the company's valuation and future growth prospects within the quantum computing sector, comparing QUBT to its peers. Some traders anticipate a continued upward trend, while others express caution, citing high valuation metrics and mixed earnings results.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber ($WYFI) is trending as investors discuss its potential in the AI data center space following its recent IPO. Community members are pointing to the company's low float and potential connection to Tom Lee as catalysts, while also highlighting Bit Digital's ($BTBT) stake in WhiteFiber and the potential for strategic moves. The focus is on upcoming news and contracts related to WhiteFiber's AI infrastructure and data center capabilities.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending amid increasing community excitement around its potential move into AI data centers and high-performance computing, with analysts suggesting a significant revaluation could be on the horizon. Traders are closely watching key resistance levels, fueled by bullish sentiment and anticipation that CLSK will catch up to its peers in the mining sector. The community highlights the company's strong fundamentals, low debt, and significant short interest as additional factors driving current interest.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

UPC is trending due to its low float and high cash per share, leading to community speculation about a potential squeeze. Some traders are comparing it to previous runners like $BREA and $AGMH, while others anticipate news related to crypto.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics ($AQST) is trending amid increased community discussion fueled by a recent mention on Cramer's Mad Money and anticipation surrounding their drug Anaphylm.  The community is actively debating the potential impact of a positive FDA decision (PDUFA date 01/31/2026) and speculating on buyout possibilities. Bullish sentiment is countered by some skepticism regarding product pipeline and revenue.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending due to Nvidia's significant investment and partnership, sparking optimism about Intel's role in AI and chip manufacturing. The community is discussing potential foundry deals and future collaborations with companies like Tesla and Apple. Some analysts have upgraded their price targets, while others remain skeptical, focusing on Intel's execution and competitive challenges.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why

J&J sees Innovative Medicines growth in 2025, fueled by oncology and immunology drugs, despite steep Stelara sales erosion.

NVO Stock Rises on Upbeat Phase III Data for Cagrilintide in Obesity

Novo Nordisk stock rises as its next-generation subcutaneous obesity treatment candidate, cagrilintide, delivers meaningful weight loss in a phase III obesity study.

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?

Amgen's MariTide and Viking's VK2735 show promise in obesity, but pipeline strength and performance set the two biotech players apart.

Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?

Eli Lilly shares move past the 50-day SMA as weight-loss drug data, rising sales and pipeline momentum fuel optimism.

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Where Does VKTX Stock Stand After the Obesity Pill Setback?

Viking Therapeutics faces pressure after mixed oral obesity pill trial results, raising safety concerns but still meeting key study goals.

Is NVO's Major Restructuring Plan an Indication to Sell the Stock?

Novo Nordisk's sweeping restructuring plan cuts 9,000 jobs, targets DKK 8 billion in savings, and shifts focus to obesity and diabetes R&D.

Zai Lab (ZLAB) announced on Wednesday that it plans to await the results of a trial evaluating Bemarituzumab in combination with Nivolumab and chemotherapy before filing for regulatory approval for the experimental cancer drug.The data from the trial is expected by the end of 2025 or the first half of 2026, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0903/2025090302254.pdf">said</a> in a filing with the Hong Kong stock exchange. Nasdaq-listed <a href="https://stocktwits.com/symbol/ZLAB">shares of Zai Lab</a> were down 4% at the time of writing.On Stocktwits, retail sentiment around ZLAB stayed within ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.The announcement from the company follows its partner Amgen's (AMGN) completion of the final analysis of the late-stage trial evaluating Bemarituzumab in combination with Chemotherapy in first-line gastric cancer.Amgen <a href="https://stocktwits.com/news-articles/markets/equity/amgen-cancer-drug-improves-survival-in-late-stage-trial/chmZZAcRR79">said</a> in late June that Bemarituzumab plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival as compared to placebo plus chemotherapy in people living with certain types of unresectable locally advanced or metastatic gastric or gastroesophageal junction cancer. Overall survival refers to the total length of time a patient with cancer remains alive after diagnosis or the initiation of treatment.However, Zai Lab said on Wednesday that, upon final analysis of the trial, the magnitude of the previously observed survival benefit was reduced, leading the company to await the results of another trial.Zai Lab holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.ZLAB shares are up 22% this year and approximately 66% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/ford-reports-near-four-percent-jump-in-us-vehicle-sales-in-august/chwT6RHRd8r">Ford Reports Near 4% Jump In US Vehicle Sales In August</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Zai Lab company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Zai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer Drug

The company holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.

Equity

The company holds co-development and commercialization rights for Bemarituzumab for mainland China, Hong Kong, Macau, and Taiwan.


Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$275.83
Prev Close	$274.71
Open	$274.70
Dividend Yield	3.45%
50-Day Moving Average	$291.02
Beta	0.47
Avg. Volume	2.06M
PE Ratio	22.57

52-Week High	$339.17
52-Week Low	$253.30
Market Capitalization	$148.5B
EPS (Annual)	$7.56
Price to Book	19.99
Revenue Per Employee	$1.19M
Enterprise Value/EBITDA	N/A

AMGN
AMGEN Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMGN News

AMGN AMGEN Inc.